Search results
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 6 days ago(Nasdaq: CTKB) announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China National Medical Products Administration (NMPA) approval for clinical ...
Tips For Building Credit For Startup Businesses | Bankrate
Bankrate.com· 4 days agoFor many entrepreneurs, starting a small business is no small financial feat. According to 2024...
SCORE is on a pace locally to help over 700 businesses this year
The Bulletin· 3 days agoSCORE in Central Oregon is part of a nationwide volunteer organization under the Small Business ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 16 hours agoTuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma
Small Business - Picayune Item | Picayune Item
The Picayune Item· 1 day ago“As our company is now increasingly focused on our lead asset petosemtamab and plan to initiate phase 3 trials in head and neck cancer later this year, we aim to advance clinical ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 1 day agoFood and Drug Administration (FDA) for its investigational radiodiagnostic PET1 agent, TLX250-CDx (Zircaix™2, 89Zr-DFO-girentuximab), for the characterisation of renal masses ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 17 hours ago(NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the US Food and Drug ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoAn additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacySYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in mUC and 43% ORR and 86% DCR in cervical cancer to date at doses
Mandatory Cybersecurity Incident Reporting: The Dawn of a New Era for Businesses
The National Law Review· 14 hours agoA significant shift in cybersecurity compliance is on the horizon, and businesses need to prepare....
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 17 hours agoIN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies, presented encouraging preliminary clinical data of INB-200 at ...
